These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. History and challenges surrounding ovarian stimulation in the treatment of infertility. Beall SA; DeCherney A Fertil Steril; 2012 Apr; 97(4):795-801. PubMed ID: 22463773 [TBL] [Abstract][Full Text] [Related]
6. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports. Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932 [TBL] [Abstract][Full Text] [Related]
7. Etiology of OHSS and use of dopamine agonists. Soares SR Fertil Steril; 2012 Mar; 97(3):517-22. PubMed ID: 22265002 [TBL] [Abstract][Full Text] [Related]
10. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Garcia-Velasco JA Fertil Steril; 2012 Mar; 97(3):527-8. PubMed ID: 22222191 [TBL] [Abstract][Full Text] [Related]
11. Reducing the trigger dose of recombinant hCG in high-responder patients attending an assisted reproductive technology program: an observational study. Tiboni GM; Colangelo EC; Ponzano A Drug Des Devel Ther; 2016; 10():1691-4. PubMed ID: 27274202 [TBL] [Abstract][Full Text] [Related]
12. Ovarian hyperstimulation syndrome associated with clomiphene citrate. Mitchell SY; Fletcher HM; Williams E West Indian Med J; 2001 Sep; 50(3):227-9. PubMed ID: 11769032 [TBL] [Abstract][Full Text] [Related]
13. Agonist trigger: what is the best approach? Agonist trigger and low dose hCG. Humaidan P Fertil Steril; 2012 Mar; 97(3):529-30. PubMed ID: 22154368 [TBL] [Abstract][Full Text] [Related]
14. Management of ovarian hyperstimulation syndrome guidelines. Produced on behalf of the BFS Policy and Practice Committee. Tan BK; Mathur R; Hum Fertil (Camb); 2013 Sep; 16(3):160-1. PubMed ID: 23705631 [No Abstract] [Full Text] [Related]
15. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269 [TBL] [Abstract][Full Text] [Related]
16. Low dose of rFSH [100 IU] in controlled ovarian hyperstimulation response: a pilot study. Barbosa CP; Cordts EB; Costa AC; de Oliveira R; de Mendonça MA; Christofolini DM; Bianco B J Ovarian Res; 2014 Jan; 7():11. PubMed ID: 24447686 [TBL] [Abstract][Full Text] [Related]